$SPGC
Sacks Parente Golf, Inc. Stock $spgc

$spgc Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224010203 Filed on March 18, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023 Q3
Revenue	$350.0K	$117.0K	$95.00K
YoY Change	288.89%	290.0%	-99.8%
Cost Of Revenue	$144.0K	$93.00K	$56.00K
YoY Change	188.0%	132.5%	-99.79%
Gross Profit	$206.0K	$24.00K	$39.00K
YoY Change	415.0%	-340.0%	-99.81%
Gross Profit Margin	58.86%	20.51%	41.05%
Selling, General & Admin	$1.271M	$1.722M	$1.195M
YoY Change	39.67%	291.36%	-99.77%
% of Gross Profit	616.99%	7175.0%	3064.1%
Research & Development	$190.0K	$200.0K	$15.00K
YoY Change	533.33%	566.67%	-99.95%
% of Gross Profit	92.23%	833.33%	38.46%
Depreciation & Amortization	$21.00K	$17.00K	$10.00K
YoY Change	110.0%		-99.67%
% of Gross Profit	10.19%	70.83%	25.64%
Operating Expenses	$1.461M	$1.939M	$1.210M
YoY Change	55.43%	303.96%	-99.78%
Operating Profit	-$1.255M	-$1.915M	-$1.171M
YoY Change	39.44%	290.82%	-99.78%
Interest Expense	$62.00K	$76.00K	$26.00K
YoY Change	-410.0%	-290.0%	-100.16%
% of Operating Profit
Other Income/Expense, Net			-$26.00K
YoY Change			62.5%
Pretax Income	-$1.193M	-$1.839M	-$1.200M
YoY Change	29.67%	253.65%	-99.78%
Income Tax
% Of Pretax Income
Net Earnings	-$1.193M	-$1.839M	-$1.197M
YoY Change	29.67%	253.65%	-99.78%
Net Earnings / Revenue	-340.86%	-1571.79%	-1260.0%
Basic Earnings Per Share	-$0.08		-$0.09
Diluted Earnings Per Share	-$0.08	-$0.13	-$0.09
COMMON SHARES
Basic Shares Outstanding	14.60M shares	14.60M shares	14.60M shares
Diluted Shares Outstanding	14.60M shares		12.67M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.083M	$5.338M	$6.770M
YoY Change	13510.0%	3458.67%	-88.12%
Cash & Equivalents	$4.083M	$5.338M	$6.768M
Short-Term Investments
Other Short-Term Assets	$234.0K	$196.0K	$770.0K
YoY Change	1070.0%	390.0%	-99.42%
Inventory	$336.0K	$248.0K	$165.0K
Prepaid Expenses			$766.0K
Receivables	$30.00K	$53.00K	$18.00K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.683M	$5.835M	$7.717M
YoY Change	2826.88%	1662.84%	-97.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$441.0K	$379.0K	$208.0K
YoY Change	145.0%	210.66%	-99.86%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$107.0K	$115.0K	$10.00K
YoY Change	-71.08%	-52.08%	-100.0%
Total Long-Term Assets	$606.0K	$559.0K	$255.0K
YoY Change	10.18%	47.49%	-99.93%
TOTAL ASSETS
Total Short-Term Assets	$4.683M	$5.835M	$7.717M
Total Long-Term Assets	$606.0K	$559.0K	$255.0K
Total Assets	$5.289M	$6.394M	$7.972M
YoY Change	644.93%	800.56%	-98.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$404.0K	$401.0K	$380.0K
YoY Change	39.31%	301.0%	-99.46%
Accrued Expenses	$31.00K	$31.00K	$30.00K
YoY Change	-97.92%	-97.21%	-100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$489.0K	$475.0K	$410.0K
YoY Change	-81.96%	-78.07%	-99.97%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$104.0K	$129.0K	$10.00K
YoY Change	246.67%	1190.0%	-99.9%
Total Long-Term Liabilities	$104.0K	$129.0K	$10.00K
YoY Change	246.67%	1190.0%	-99.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$489.0K	$475.0K	$410.0K
Total Long-Term Liabilities	$104.0K	$129.0K	$10.00K
Total Liabilities	$593.0K	$604.0K	$419.0K
YoY Change	-78.36%	-72.19%	-99.97%
SHAREHOLDERS EQUITY
Retained Earnings	-$11.51M	-$10.32M	-$8.478M
YoY Change		81.25%
Common Stock	$146.0K	$146.0K	$146.0K
YoY Change		35.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.696M	$5.790M	$7.553M
YoY Change
Total Liabilities & Shareholders Equity	$5.289M	$6.394M	$7.972M
YoY Change	644.93%	800.56%	-98.8%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$1.193M	-$1.839M	-$1.197M
YoY Change	29.67%	253.65%	-99.78%
Depreciation, Depletion And Amortization	$21.00K	$17.00K	$10.00K
YoY Change	110.0%		-99.67%
Cash From Operating Activities	-$1.151M	-$1.242M	-$3.500M
YoY Change	505.79%	491.43%	-98.83%
INVESTING ACTIVITIES
Capital Expenditures	$83.00K	$188.0K	$100.0K
YoY Change			-99.75%
Acquisitions
YoY Change
Other Investing Activities	-$21.00K
YoY Change
Cash From Investing Activities	-$104.0K	-$188.0K	-$100.0K
YoY Change			-99.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		3.000K	10.35M
YoY Change		-98.75%	-87.82%
NET CHANGE
Cash From Operating Activities	-$1.151M	-1.242M	-3.500M
Cash From Investing Activities	-$104.0K	-188.0K	-100.0K
Cash From Financing Activities		3.000K	10.35M
Net Change In Cash	-$1.255M	-1.430M	6.750M
YoY Change	796.43%	-4866.67%	-102.65%
FREE CASH FLOW
Cash From Operating Activities	-$1.151M	-$1.242M	-$3.500M
Capital Expenditures	$83.00K	$188.0K	$100.0K
Free Cash Flow	-$1.234M	-$1.430M	-$3.600M
YoY Change	549.47%	580.95%	-98.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001934245
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2022Q4	SPGC	Deferred Software Licensing Agreement DeferredSoftwareLicensingAgreement		usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts		usd
CY2023Q4	SPGC	Accrued Payroll Current AccruedPayrollCurrent		usd
CY2022Q4	SPGC	Deferred Software Licensing Obligation Current DeferredSoftwareLicensingObligationCurrent		usd
CY2023Q4	SPGC	Equipment Purchase Obligation Current EquipmentPurchaseObligationCurrent		usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent		usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2022Q4	SPGC	Software Licensing Fee Obligation Noncurrent SoftwareLicensingFeeObligationNoncurrent		usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization		usd
CY2023	SPGC	Vesting Of Restricted Stock VestingOfRestrictedStock		usd
CY2023	SPGC	Modification Of Equity Awards ModificationOfEquityAwards		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2023	SPGC	Gain Loss On Accrued Interest GainLossOnAccruedInterest		usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022	SPGC	Repayment Of Loans Payable Related Party RepaymentOfLoansPayableRelatedParty		usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	SPGC	Recording Of Deferred Software Licensing Agreement RecordingOfDeferredSoftwareLicensingAgreement		usd
CY2023	SPGC	Property And Equipment Purchased With Debt PropertyAndEquipmentPurchasedWithDebt		usd
CY2022	SPGC	Reclass Of Common Stock Subject To Redemption To Equity ReclassOfCommonStockSubjectToRedemptionToEquity		usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent		usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41701
CY2023	dei	Entity Registrant Name EntityRegistrantName	SACKS PARENTE GOLF, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-4938288
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	551 Calle San Pablo
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Camarillo
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	93012
CY2023	dei	City Area Code CityAreaCode	(855)
CY2023	dei	Local Phone Number LocalPhoneNumber	774-7888
CY2023	dei	Security12b Title Security12bTitle	Common Stock
CY2023	dei	Trading Symbol TradingSymbol	SPGC
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	11204000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14595870	shares
CY2023	dei	Auditor Firm AuditorFirmId	572
CY2023	dei	Auditor Name AuditorName	Weinberg & Company, P.A
CY2023	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5338000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	147000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	24000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	53000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	98000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	73000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	248000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	142000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	196000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	5835000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	331000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	379000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	122000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	65000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22000	usd
CY2023Q4	SPGC	Deferred Software Licensing Agreement DeferredSoftwareLicensingAgreement	110000	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	230000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	5000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	5000	usd
CY2023Q4	us-gaap	Assets Assets	6394000	usd
CY2022Q4	us-gaap	Assets Assets	710000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	401000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	97000	usd
CY2022Q4	SPGC	Accrued Payroll Current AccruedPayrollCurrent	1095000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	31000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	17000	usd
CY2023Q4	SPGC	Deferred Software Licensing Obligation Current DeferredSoftwareLicensingObligationCurrent	41000	usd
CY2022Q4	SPGC	Equipment Purchase Obligation Current EquipmentPurchaseObligationCurrent	15000	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	537000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	384000	usd
CY2023Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	2000	usd
CY2022Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	21000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	475000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2166000	usd
CY2023Q4	SPGC	Software Licensing Fee Obligation Noncurrent SoftwareLicensingFeeObligationNoncurrent	95000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	604000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2172000	usd
CY2022Q4	SPGC	Temporary Equity Redemption Of Shares TemporaryEquityRedemptionOfShares	561375	shares
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	1.07
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	420000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14595870	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14595870	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10784495	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10784495	shares
CY2022Q4	SPGC	Temporary Equity Redemption Of Shares TemporaryEquityRedemptionOfShares	561375	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	146000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	108000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15961000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3702000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10317000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5692000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	5790000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1882000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6394000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	710000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	349000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	190000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	227000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	110000	usd
CY2023	us-gaap	Gross Profit GrossProfit	122000	usd
CY2022	us-gaap	Gross Profit GrossProfit	80000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4497000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2874000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	258000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	73000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	4755000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	2947000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-4633000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2867000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-574000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	8000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-64000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4625000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3505000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12237395	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12237395	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10433820	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10433820	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1437000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	25000	usd
CY2022	SPGC	Stock Issued During Period Value Vesting Of Options StockIssuedDuringPeriodValueVestingOfOptions	1383000	usd
CY2022	SPGC	Stock Issued During Period Value Modification Of Equity Awards StockIssuedDuringPeriodValueModificationOfEquityAwards	28000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1624000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3505000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1882000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1882000	usd
CY2023	SPGC	Stock Issued During Period Value Vesting Of Options StockIssuedDuringPeriodValueVestingOfOptions	443000	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	225000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	600000	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	11029000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4625000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	5790000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	5790000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4625000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3505000	usd
CY2023	us-gaap	Depreciation Depreciation	32000	usd
CY2022	us-gaap	Depreciation Depreciation	11000	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	26000	usd
CY2023	SPGC	Gain Loss On Inventory Obsolescence GainLossOnInventoryObsolescence	-25000	usd
CY2022	SPGC	Gain Loss On Inventory Obsolescence GainLossOnInventoryObsolescence	36000	usd
CY2023	SPGC	Vesting Of Options VestingOfOptions	443000	usd
CY2022	SPGC	Vesting Of Options VestingOfOptions	1383000	usd
CY2022	SPGC	Vesting Of Restricted Stock VestingOfRestrictedStock	25000	usd
CY2022	SPGC	Modification Of Equity Awards ModificationOfEquityAwards	28000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-574000	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	225000	usd
CY2023	SPGC	Changes In Right Of Use Asset ChangesInRightOfUseAsset	30000	usd
CY2022	SPGC	Changes In Right Of Use Asset ChangesInRightOfUseAsset	12000	usd
CY2022	SPGC	Gain Loss On Accrued Interest GainLossOnAccruedInterest	-63000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	51000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-9000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	131000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	62000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	180000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	190000	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	1000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	304000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	88000	usd
CY2023	SPGC	Increase Decreasein Accrued Payroll IncreaseDecreaseinAccruedPayroll	-1095000	usd
CY2022	SPGC	Increase Decreasein Accrued Payroll IncreaseDecreaseinAccruedPayroll	615000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-31000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-11000	usd
CY2023	SPGC	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	-19000	usd
CY2022	SPGC	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	18000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5047000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-785000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	289000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	75000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-289000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-75000	usd
CY2023	SPGC	Payments Of Equipment Purchase Obligation PaymentsOfEquipmentPurchaseObligation	15000	usd
CY2022	SPGC	Payments Of Equipment Purchase Obligation PaymentsOfEquipmentPurchaseObligation	43000	usd
CY2023	SPGC	Repayment Of Deferred Offering Costs RepaymentOfDeferredOfferingCosts	-230000	usd
CY2022	SPGC	Repayment Of Deferred Offering Costs RepaymentOfDeferredOfferingCosts	230000	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	180000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	420000	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	11029000	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	61000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	350000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	445000	usd
CY2023	SPGC	Proceeds From Loans Payable Related Party ProceedsFromLoansPayableRelatedParty	20000	usd
CY2022	SPGC	Proceeds From Loans Payable Related Party ProceedsFromLoansPayableRelatedParty	200000	usd
CY2023	SPGC	Repayment Of Loans Payable Related Party RepaymentOfLoansPayableRelatedParty	557000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	150000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10503000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	847000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5167000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	171000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	184000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5338000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	171000	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	1624000	usd
CY2023	SPGC	New Right Of Use Asset And Lease Liability NewRightOfUseAssetAndLeaseLiability	73000	usd
CY2022	SPGC	New Right Of Use Asset And Lease Liability NewRightOfUseAssetAndLeaseLiability	34000	usd
CY2023	SPGC	Recording Of Deferred Software Licensing Agreement RecordingOfDeferredSoftwareLicensingAgreement	136000	usd
CY2022	SPGC	Property And Equipment Purchased With Debt PropertyAndEquipmentPurchasedWithDebt	58000	usd
CY2023	SPGC	Reclass Of Common Stock Subject To Redemption To Equity ReclassOfCommonStockSubjectToRedemptionToEquity	420000	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_807_eus-gaap--NatureOfOperations_z3SxdP0P9dH4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_82E_zuRopwOnoGFh">OPERATIONS AND LIQUIDITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sacks Parente Golf, Inc. (“we,” the “Company” or “SPG”) was formed in 2018 as Sacks Parente Golf Company, LLC, a Delaware limited liability company. On March 18, 2022 the Company converted into a Delaware corporation named Sacks Parente Golf, Inc. Pursuant to our Plan of Conversion, on March 18, 2022, all of the outstanding ownership interests in Sacks Parente Golf Company, LLC, and rights to receive such interest were converted into and exchanged for shares of capital stock of Sacks Parente Golf, Inc. The Company retroactively reflected the conversion as of the earliest periods presented herein.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sacks Parente Golf, Inc. is a technology-forward golf company, with a growing portfolio of golf products, including putting instruments, golf shafts, golf grips, and other golf-related products. In consideration of its growth opportunities in shaft technologies, in April of 2022, the Company expanded its manufacturing business to include advanced premium golf shafts by opening a new shaft manufacturing facility in St. Joseph, MO. It is the Company’s intent to manufacture and assemble substantially all products in the United States. The Company anticipates expansion into golf apparel and other golf-related product lines to enhance its growth. The Company’s future expansions may include broadening its offerings through mergers, acquisitions or internal developments of product lines that are complementary to its premium brand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company currently sells its products through resellers, the Company’s websites, and distributors in the United States, Japan, and South Korea.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going Concern and Liquidity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, during the year ended December 31, 2023, the Company incurred a net loss of $<span id="xdx_90A_eus-gaap--NetIncomeLoss_iN_di_c20230101__20231231_zxCd4j4dFguk" title="Net loss">4,625,000</span> and used cash in operations of $<span id="xdx_909_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20230101__20231231_zTfY9vEsPTEb" title="Net cash used in operating activities">5,047,000</span>. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date of the financial statements being issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, the Company closed its initial public offering (“IPO”) and received $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230101__20231231_zL8V89SyeRg4" title="Issuance of initial public offering">11,029,000</span> of net proceeds after expenses. At December 31, 2023, the Company had cash and cash equivalents on hand in the amount of $<span id="xdx_90C_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20231231_zxkGMq7Rk25" title="Cash and cash equivalents">5,338,000</span>. Due to the funds received through our IPO, and the $<span id="xdx_909_eus-gaap--Cash_iI_c20231231_zD03ic0BLKW2" title="Cash">600,000 </span>cash received that was reclassified to additional paid in capital (see Note 11), the Company had shareholders’ equity of $<span id="xdx_908_eus-gaap--StockholdersEquity_iI_c20231231_zTxfCa7jyZXf" title="Stockholders equity">5,790,000</span> at December 31, 2023. The Company expects its cash on hand on December 31, 2023, will last for at least the next 12 months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The continuation of the Company as a going concern is dependent upon its ability to obtain necessary debt or equity financing to continue operations until it begins generating positive cash flow. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders, in case or equity financing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in case of equity financing, or grant unfavorable terms in licensing future licensing agreements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nasdaq Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 5, 2023, the Company received a written notice (the “Notice”) from the NASDAQ Stock Market LLC (“Nasdaq”) that the Company has not been in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for a period of 30 consecutive business days. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum closing bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum closing bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. The Notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Capital Market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company is provided a compliance period of 180 calendar days from the date of the Notice, or until June 3, 2024, to regain compliance with the minimum closing bid price requirement. If the Company does not regain compliance during the compliance period ending June 3, 2024, the Company may be afforded a second 180 calendar day period to regain compliance. To qualify for the second compliance period, the Company must (i) meet the continued listing requirement for market value of publicly-held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of the minimum closing bid price requirement, and (ii) notify Nasdaq of its intent to cure the deficiency. The Company can achieve compliance with the minimum closing bid price requirement if, during either compliance period, the minimum closing bid price per share of the Company’s common stock is at least $1.00 for a minimum of 10 consecutive business days. The Company anticipates that its shares of common stock will continue to be listed and traded on the Nasdaq Capital Market during the compliance period(s).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company plans to carefully assess potential actions to regain compliance. However, the Company may be unable to regain compliance with the minimum closing bid price requirement during the compliance period(s), in which case the Company anticipates Nasdaq would provide a notice to the Company that its shares of common stock are subject to delisting, and the Company’s common shares would thereupon be delisted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4625000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5047000	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	11029000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5338000	usd
CY2023Q4	us-gaap	Cash Cash	600000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	5790000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zONPJTZi1uR4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zuscDQBOsoB7">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for reserves of uncollectible accounts receivables, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term and tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, and assumptions made in valuing stock instruments issued for services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	349000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	190000	usd
CY2023	SPGC	Change In Revenue Percentage ChangeInRevenuePercentage	0.84	pure
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	349000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	98000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	73000	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2561603	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2782210	shares
CY2023	us-gaap	Advertising Expense AdvertisingExpense	827000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	283000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	258000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	73000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	73000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zRUfHtTnE2Mi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zvuAyzKXKXKb">Concentrations of Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash Balances.</i> The Company’s cash balances on deposits with banks are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $<span id="xdx_90A_eus-gaap--CashFDICInsuredAmount_iI_c20231231_ztlrKUyc9Eo" title="Cash balances on deposits FDIC">250,000</span>. From time to time, however, the Company may be exposed to risk for the amounts of funds held in bank accounts in excess of the FDIC limit. To minimize the risk, the Company’s policy is to maintain cash balances with high quality financial institutions. All of the non-interest bearing cash balances were fully insured at December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts Receivable.</i> At December 31, 2023, one customer accounted for <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--Customer1Member_z9oV0GJE4c09" title="Concentration risk, percentage">100</span>% of accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net sales.</i> During the year ended December 31, 2023, one customer classified as a distributor accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetSalesMember__srt--MajorCustomersAxis__custom--DistributorsMember_zG1HkjCJNdLa" title="Concentration risk, percentage">26</span>% of net sales. No other customers exceeded 10% of net sales. During the year ended December 31, 2023, approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetSalesMember__srt--StatementGeographicalAxis__country--US_zX4a0mxRwbFd" title="Concentration risk, percentage">74</span>% of the Company’s net sales were in the United States, and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetSalesMember__srt--StatementGeographicalAxis__country--KR_zXQAXcyOJYJf" title="Concentration risk, percentage">26</span>% of the Company’s net sales were in South Korea.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company’s two largest customers classified as distributors, accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetSalesMember__srt--MajorCustomersAxis__custom--Customer1Member_zVfq6J84oFf9" title="Concentration risk, percentage">18</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetSalesMember__srt--MajorCustomersAxis__custom--Customer2Member_zkxbXwf50QI7" title="Concentration risk, percentage">13</span>% of net sales, respectively. No other customers exceeded 10% of net sales. During the twelve months ended December 31, 2022, <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetSalesMember__srt--StatementGeographicalAxis__country--US_zj0nJnZpOT59" title="Concentration risk, percentage">79</span>% of the Company’s net sales were in the United States, with the remaining 21% net sales split between Japan <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetSalesMember__srt--StatementGeographicalAxis__country--JP_zqz14AgOuN1b" title="Concentration risk, percentage">18</span>% and other countries making up the last <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetSalesMember__srt--StatementGeographicalAxis__custom--OtherCountriesMember_zlf55LFBCjU7" title="Concentration risk, percentage">3</span>% of net sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	74000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	42000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	174000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	100000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	248000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	142000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	98000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	43000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	379000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	122000	usd
CY2023	us-gaap	Depreciation Depreciation	32000	usd
CY2022	us-gaap	Depreciation Depreciation	11000	usd
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	58000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1095000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1095000	usd
CY2022Q2	us-gaap	Purchase Obligation PurchaseObligation	58000	usd
CY2022Q2	SPGC	Purchase Obligation Monthly Payment PurchaseObligationMonthlyPayment	5000	usd
CY2022Q4	us-gaap	Purchase Obligation PurchaseObligation	15000	usd
CY2023	SPGC	Payments Of Equipment Purchase Obligation PaymentsOfEquipmentPurchaseObligation	15000	usd
CY2023Q4	us-gaap	Professional Fees ProfessionalFees	34000	usd
CY2023Q4	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	136000	usd
CY2023Q4	us-gaap	Payments For Software PaymentsForSoftware	4513	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	26000	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	537000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	384000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	65000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	23000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	65000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	31000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34000	usd
CY2023	us-gaap	Lease Cost LeaseCost	84000	usd
CY2022	us-gaap	Lease Cost LeaseCost	67000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1000	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	36000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	36000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	72000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	65000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	31000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34000	usd
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	561375	shares
CY2023Q4	us-gaap	Cash Cash	600000	usd
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1050000	usd
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1517865	shares
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1624000	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	574000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2220835	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.00
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2220835	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.00
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1168000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.83
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	827232	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.00
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2561603	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.01
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1388589	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.00
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2561603	shares
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y3M3D
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	1.01
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1388589	shares
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	1.00
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	443000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1383000	usd
CY2023Q4	SPGC	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1	873000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Price SharePrice	0.67
CY2023Q3	us-gaap	Marketing Expense MarketingExpense	2500000	usd
CY2023Q3	us-gaap	Escrow Deposit EscrowDeposit	500000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	500000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	5437000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.060	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.060	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.2700	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.2700	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1468000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	400000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1468000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	400000	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-24-010203-index-headers.html	Edgar Link	pending
0001493152-24-010203-index.html	Edgar Link	pending
0001493152-24-010203.txt	Edgar Link	pending
0001493152-24-010203-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex97-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
spgc-20231231.xsd	Edgar Link	pending
spgc-20231231_lab.xml	Edgar Link	unprocessable
spgc-20231231_def.xml	Edgar Link	unprocessable
spgc-20231231_pre.xml	Edgar Link	unprocessable
spgc-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SPGC
Sacks Parente Golf, Inc. Stock $spgc

2024 Q1 Form 10-K Financial Statement

#000149315224010203 Filed on March 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SPGC Sacks Parente Golf, Inc. Stock $spgc

2024 Q1 Form 10-K Financial Statement

#000149315224010203 Filed on March 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SPGC
Sacks Parente Golf, Inc. Stock $spgc